{"count": 31, "results": [{"_id": "35645803", "pmid": 35645803, "pmcid": "PMC9136048", "title": "Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis", "journal": "Front Pharmacol", "authors": ["Jiao Y", "Liu D", "Sun Y", "Chen Z", "Liu S"], "date": "2022-05-13T00:00:00Z", "doi": "10.3389/fphar.2022.850750", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "850750", "score": 50285.75, "text_hl": "Survival Benefit of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as an Adjuvant Treatment for @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@Head and Neck Cancer@@@: A Systematic Review and Meta-Analysis", "citations": {"NLM": "Jiao Y, Liu D, Sun Y, Chen Z, Liu S. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis Front Pharmacol. 2022;13():850750. PMID: 35645803", "BibTeX": "@article{35645803, title={Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis}, author={Jiao Y and Liu D and Sun Y and Chen Z and Liu S}, journal={Front Pharmacol}, volume={13}, pages={850750}}"}}, {"_id": "37834839", "pmid": 37834839, "pmcid": "PMC10573641", "title": "Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review", "journal": "J Clin Med", "authors": ["Bouland C", "Vanden Eynden X", "Lalmand M", "Buset T", "Yanni A", "Javadian R", "Rodriguez A", "Loeb I", "Lechien JR", "Journe F", "Saussez S", "Dequanter D"], "date": "2023-09-25T00:00:00Z", "doi": "10.3390/jcm12196195", "meta_date_publication": "2023 Sep 25", "meta_volume": "12", "meta_issue": "19", "meta_pages": "", "score": 50285.24, "text_hl": "Preventive and Therapeutic Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@Head and Neck Cancer@@@: A Concise Review", "citations": {"NLM": "Bouland C, Vanden Eynden X, Lalmand M, Buset T, Yanni A, Javadian R, Rodriguez A, Loeb I, Lechien JR, Journe F, Saussez S, Dequanter D. Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review J Clin Med. 2023 Sep 25;12(19):. PMID: 37834839", "BibTeX": "@article{37834839, title={Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review}, author={Bouland C and Vanden Eynden X and Lalmand M and Buset T and Yanni A and Javadian R and Rodriguez A and Loeb I and Lechien JR and Journe F and Saussez S and Dequanter D}, journal={J Clin Med}, volume={12}, number={19}}"}}, {"_id": "36547172", "pmid": 36547172, "pmcid": "PMC9777346", "title": "Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study", "journal": "Curr Oncol", "authors": ["Spoerl S", "Gerken M", "Schimnitz S", "Taxis J", "Fischer R", "Lindner SR", "Ettl T", "Ludwig N", "Spoerl S", "Reichert TE", "Spanier G"], "date": "2022-12-07T00:00:00Z", "doi": "10.3390/curroncol29120758", "meta_date_publication": "2022 Dec 7", "meta_volume": "29", "meta_issue": "12", "meta_pages": "9660-9670", "score": 50275.3, "text_hl": "Prognostic Relevance of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment in @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@Head and Neck Melanoma@@@: Results from a Population-Based Cohort Study", "citations": {"NLM": "Spoerl S, Gerken M, Schimnitz S, Taxis J, Fischer R, Lindner SR, Ettl T, Ludwig N, Spoerl S, Reichert TE, Spanier G. Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study Curr Oncol. 2022 Dec 7;29(12):9660-9670. PMID: 36547172", "BibTeX": "@article{36547172, title={Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study}, author={Spoerl S and Gerken M and Schimnitz S and Taxis J and Fischer R and Lindner SR and Ettl T and Ludwig N and Spoerl S and Reichert TE and Spanier G}, journal={Curr Oncol}, volume={29}, number={12}, pages={9660-9670}}"}}, {"_id": "35327549", "pmid": 35327549, "pmcid": "PMC8945547", "title": "Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models", "journal": "Biomolecules", "authors": ["Morale MG", "Tamura RE", "Rubio IGS"], "date": "2022-02-24T00:00:00Z", "doi": "10.3390/biom12030357", "meta_date_publication": "2022 Feb 24", "meta_volume": "12", "meta_issue": "3", "meta_pages": "", "score": 50256.95, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Cancer@@@ Hallmarks: Molecular Mechanisms in @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@Thyroid, Prostate and Head and Neck Cancer@@@ Models", "citations": {"NLM": "Morale MG, Tamura RE, Rubio IGS. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models Biomolecules. 2022 Feb 24;12(3):. PMID: 35327549", "BibTeX": "@article{35327549, title={Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models}, author={Morale MG and Tamura RE and Rubio IGS}, journal={Biomolecules}, volume={12}, number={3}}"}}, {"_id": "37602474", "pmid": 37602474, "title": "NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.", "journal": "Biochem Cell Biol", "authors": ["Wang Z", "Tao E", "Chen Y", "Wang Q", "Liu M", "Wei L", "Xu S", "Chen W", "Zhong C"], "date": "2023-08-21T00:00:00Z", "doi": "10.1139/bcb-2023-0018", "meta_date_publication": "2023 Aug 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.395, "text_hl": "Therefore, @GENE_NDUFA4 @GENE_17992 @@@NDUFA4@@@ deficiency enhanced @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-mediated inhibition of the @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@HNPGL@@@ progression in mice. ", "citations": {"NLM": "Wang Z, Tao E, Chen Y, Wang Q, Liu M, Wei L, Xu S, Chen W, Zhong C. NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis. Biochem Cell Biol. 2023 Aug 21;():. PMID: 37602474", "BibTeX": "@article{37602474, title={NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.}, author={Wang Z and Tao E and Chen Y and Wang Q and Liu M and Wei L and Xu S and Chen W and Zhong C}, journal={Biochem Cell Biol}}"}}, {"_id": "32067604", "pmid": 32067604, "title": "The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.", "journal": "Curr Pharm Des", "authors": ["Wang Y", "Fu T", "Liu Y", "Yang G", "Yu C", "Zhang ZJ"], "date": "2020-01-01T00:00:00Z", "doi": "10.2174/1381612826666200218095310", "meta_date_publication": "2020", "meta_volume": "26", "meta_issue": "26", "meta_pages": "3161-3170", "score": 50255.492, "text_hl": "The Association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Survival of @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@Head and Neck Cancer@@@: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.", "citations": {"NLM": "Wang Y, Fu T, Liu Y, Yang G, Yu C, Zhang ZJ. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies. Curr Pharm Des. 2020;26(26):3161-3170. PMID: 32067604", "BibTeX": "@article{32067604, title={The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.}, author={Wang Y and Fu T and Liu Y and Yang G and Yu C and Zhang ZJ}, journal={Curr Pharm Des}, volume={26}, number={26}, pages={3161-3170}}"}}, {"_id": "39463147", "pmid": 39463147, "title": "Oncogenic H-RAS induces metformin resistance in head and neck cancer by promoting glycolytic metabolism.", "journal": "Cancer Prev Res (Phila)", "authors": ["Wu X", "Adame-Garcia SR", "Koshizuka K", "Vo PTT", "Hoang TS", "Sato K", "Izumi H", "Goto Y", "Allevato MM", "Wood KC", "Lippman SM", "Gutkind JS"], "date": "2024-10-28T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-24-0124", "meta_date_publication": "2024 Oct 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.336, "text_hl": "Oncogenic @GENE_HRAS @GENE_3265 @@@H-RAS@@@ induces @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ resistance in @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@head and neck cancer@@@ by promoting glycolytic metabolism.", "citations": {"NLM": "Wu X, Adame-Garcia SR, Koshizuka K, Vo PTT, Hoang TS, Sato K, Izumi H, Goto Y, Allevato MM, Wood KC, Lippman SM, Gutkind JS. Oncogenic H-RAS induces metformin resistance in head and neck cancer by promoting glycolytic metabolism. Cancer Prev Res (Phila). 2024 Oct 28;():. PMID: 39463147", "BibTeX": "@article{39463147, title={Oncogenic H-RAS induces metformin resistance in head and neck cancer by promoting glycolytic metabolism.}, author={Wu X and Adame-Garcia SR and Koshizuka K and Vo PTT and Hoang TS and Sato K and Izumi H and Goto Y and Allevato MM and Wood KC and Lippman SM and Gutkind JS}, journal={Cancer Prev Res (Phila)}}"}}, {"_id": "31942181", "pmid": 31942181, "pmcid": "PMC6959048", "title": "Diabetes and its Potential Impact on Head and Neck Oncogenesis", "journal": "J Cancer", "authors": ["Wang X", "Wang H", "Zhang T", "Cai L", "Dai E", "He J"], "date": "2020-01-01T00:00:00Z", "doi": "10.7150/jca.35607", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "3", "meta_pages": "583-591", "score": 50249.906, "text_hl": "...Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and other diabetic drugs on @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@HN tumors@@@", "citations": {"NLM": "Wang X, Wang H, Zhang T, Cai L, Dai E, He J. Diabetes and its Potential Impact on Head and Neck Oncogenesis J Cancer. 2020;11(3):583-591. PMID: 31942181", "BibTeX": "@article{31942181, title={Diabetes and its Potential Impact on Head and Neck Oncogenesis}, author={Wang X and Wang H and Zhang T and Cai L and Dai E and He J}, journal={J Cancer}, volume={11}, number={3}, pages={583-591}}"}}, {"_id": "40028423", "pmid": 40028423, "title": "Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.", "journal": "Clin Transl Radiat Oncol", "authors": ["Portillo EGD", "Olivares-Hernández A", "Gudino LC", "Félix LC", "Hernández LB", "Domínguez LP", "Jiménez DL", "Sarmiento RG", "Morillo EDB", "Sánchez EF", "Miramontes-Gonzáleze JP"], "date": "2025-02-10T00:00:00Z", "doi": "10.1016/j.ctro.2025.100930", "meta_date_publication": "2025 May", "meta_volume": "52", "meta_issue": "", "meta_pages": "100930", "score": 50249.02, "text_hl": "Evaluation of the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a radiosensitiser in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@solid tumours@@@: A systematic review.", "citations": {"NLM": "Portillo EGD, Olivares-Hernández A, Gudino LC, Félix LC, Hernández LB, Domínguez LP, Jiménez DL, Sarmiento RG, Morillo EDB, Sánchez EF, Miramontes-Gonzáleze JP. Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review. Clin Transl Radiat Oncol. 2025 May;52():100930. PMID: 40028423", "BibTeX": "@article{40028423, title={Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.}, author={Portillo EGD and Olivares-Hernández A and Gudino LC and Félix LC and Hernández LB and Domínguez LP and Jiménez DL and Sarmiento RG and Morillo EDB and Sánchez EF and Miramontes-Gonzáleze JP}, journal={Clin Transl Radiat Oncol}, volume={52}, pages={100930}}"}}, {"_id": "34230113", "pmid": 34230113, "pmcid": "PMC8261884", "title": "Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects", "journal": "J Immunother Cancer", "authors": ["Veeramachaneni R", "Yu W", "Newton JM", "Kemnade JO", "Skinner HD", "Sikora AG", "Sandulache VC"], "date": "2021-07-01T00:00:00Z", "doi": "10.1136/jitc-2021-002773", "meta_date_publication": "2021 Jul", "meta_volume": "9", "meta_issue": "7", "meta_pages": "", "score": 50245.15, "text_hl": "We hypothesized that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ would generate a shift in immunity unfavorable to @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ growth and tested this hypothesis in a preclinical model of @<m>DISEASE_Head_and_Neck_Neoplasms</m> @DISEASE_MESH:D006258 @@@head and neck cancer@@@.", "citations": {"NLM": "Veeramachaneni R, Yu W, Newton JM, Kemnade JO, Skinner HD, Sikora AG, Sandulache VC. Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects J Immunother Cancer. 2021 Jul;9(7):. PMID: 34230113", "BibTeX": "@article{34230113, title={Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects}, author={Veeramachaneni R and Yu W and Newton JM and Kemnade JO and Skinner HD and Sikora AG and Sandulache VC}, journal={J Immunother Cancer}, volume={9}, number={7}}"}}]}